Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTAW) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to 11.4%.

  • Strata Critical Medical's EBIT Margin rose 82600.0% to 11.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.34%, marking a year-over-year increase of 205500.0%. This contributed to the annual value of 13.64% for FY2024, which is 166100.0% up from last year.
  • As of Q3 2025, Strata Critical Medical's EBIT Margin stood at 11.4%, which was up 82600.0% from 7.0% recorded in Q2 2025.
  • Over the past 5 years, Strata Critical Medical's EBIT Margin peaked at 7.0% during Q2 2025, and registered a low of 75.05% during Q4 2023.
  • Over the past 5 years, Strata Critical Medical's median EBIT Margin value was 22.81% (recorded in 2022), while the average stood at 30.78%.
  • Its EBIT Margin has fluctuated over the past 5 years, first crashed by -459600bps in 2021, then skyrocketed by 625400bps in 2024.
  • Strata Critical Medical's EBIT Margin (Quarter) stood at 42.8% in 2021, then dropped by -21bps to 51.6% in 2022, then crashed by -45bps to 75.05% in 2023, then skyrocketed by 83bps to 12.52% in 2024, then rose by 9bps to 11.4% in 2025.
  • Its last three reported values are 11.4% in Q3 2025, 7.0% for Q2 2025, and 13.96% during Q1 2025.